Does oxaliplatin pharmacokinetics (PKs) explain associations between body composition and chemotherapy toxicity risk in older adults with gastrointestinal (GI) cancers?

Authors

Grant Richard Williams

Grant Richard Williams

Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL

Grant Richard Williams , Mustafa Al-Obaidi , Joseph Rower , Christian Harmon , Chen Dai , Edward Acosta , Smith Giri , William Zamboni , Andrew T. Lucas , Shlomit Strulov Shachar , Olumide B. Gbolahan , Jeffrey A. Meyerhardt , Bette Jane Caan , Smita Bhatia

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Track

Developmental Therapeutics—Molecularly Targeted Agents and Tumor Biology

Sub Track

Pharmacology/Pharmacodynamics/Pharmacogenetics

Clinical Trial Registration Number

NCT03998202

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 3095)

DOI

10.1200/JCO.2021.39.15_suppl.3095

Abstract #

3095

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

Poster

2022 ASCO Annual Meeting

Myopenia and mechanisms of toxicity in older adults with colorectal cancer (CRC): The M&M study (WF-1806).

Myopenia and mechanisms of toxicity in older adults with colorectal cancer (CRC): The M&M study (WF-1806).

First Author: Grant Richard Williams

First Author: Kelsey S. Lau-Min

First Author: Robert Kudlovich

First Author: Matheus Bongers Alessandretti